Globus Medical (GMED) Stock Price & Analysis

GMED price $82.91 +1.65 +2.03%

Ticker
GMED
Price
$82.91
Change
+1.65 +2.03%
Market cap ?
$11.13B
P/E ?
20.47
Forward P/E ?
16.58
Dividend yield ?
0.00%
Beta ?
0.96
Sector
Healthcare
Industry
Medical - Devices
Stocklytics score
70
Value
58
Quality
81
Growth
71

Stocklytics score rationale: value 58, quality 81, growth 71.

Financials

2016201720182019202020212022202320242025
5639940006359770007129690007853680007890420009581020001022843000156847600025193550002938900000

Globus Medical, Inc. is a global medical technology company dedicated to inventing, developing, and marketing a diverse range of healthcare solutions. Their primary focus is on addressing musculoskeletal disorders for patients worldwide. Their extensive portfolio includes a variety of spinal products. These encompass traditional fusion implants like pedicle screw and rod systems, plating systems, intervertebral…

Fair value

GMED fair value $145.67. Price $82.91. Price is 43% below fair value.

Below fair value, and cheaper than usual. A larger discount than on 74% of days in the past 5 years.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 750.59M. Growth 10.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 9.57% (beta 1.0). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 134.26M. Net debt -407.50M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Compare GMED

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-05—1.20—792.41M
2026-08-061.341.10789.61M782.88M
2026-05-071.120.92759.85M740.35M
2026-02-241.281.06826.42M801.65M
2025-11-061.180.78769.05M734.69M
2025-08-070.860.76745.34M742.73M
2025-05-080.680.74598.12M625.89M
2025-02-200.840.74657.29M645.70M
2024-11-050.830.65625.71M604.69M
2024-08-060.750.68629.69M615.34M
2024-05-070.720.57606.67M586.82M
2024-02-200.600.59616.53M607.09M
2023-11-070.570.54383.64M268.78M
2023-08-030.630.59291.62M279.72M
2023-05-040.530.51276.69M254.90M
2023-02-210.590.56274.50M276.67M
2022-11-080.500.52254.15M253.40M
2022-08-040.560.53263.65M259.38M
2022-05-100.420.47230.55M233.89M
2022-02-170.490.48250.02M243.51M
2021-11-040.500.45229.72M228.43M
2021-08-040.560.45251.02M251.02M
2021-05-040.490.37227.34M198.69M
2021-02-170.580.51233.44M201.40M
2020-10-280.490.30216.10M132.30M
2020-08-050.07-0.11148.92M234.02M
2020-05-070.290.38190.58M249.72M
2020-02-200.490.52211.67M224.63M
2019-11-060.430.42196.22M191.65M
2019-08-010.410.41194.54M194.54M
2019-05-020.360.41182.95M208.36M
2019-02-210.430.39195.94M177.71M
2018-11-080.390.32169.24M138.86M
2018-08-010.440.35173.38M137.92M
2018-05-020.410.36174.41M153.14M
2018-02-210.380.35176.03M162.14M
2017-11-080.300.30151.74M151.74M
2017-08-020.320.30152.39M142.87M
2017-05-030.320.31155.81M150.94M
2017-02-270.310.33151.59M161.37M

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-09-15TOBIN JAMES RBuy15.00K$63.68955.20K
2026-09-15TOBIN JAMES RBuy15.00K$53.75806.25K
2026-09-15TOBIN JAMES RSell15.00K$53.75806.25K
2026-09-15TOBIN JAMES RSell15.00K$63.68955.20K
2026-09-15TOBIN JAMES RSell30.00K$74.582.24M
2026-08-18ZARRILLI STEPHEN TBuy25.00K$53.271.33M
2026-08-18ZARRILLI STEPHEN TSell25.00K$87.042.18M
2026-08-18ZARRILLI STEPHEN TSell25.00K$53.271.33M
2026-07-27Davidar David DSell2.50K——
2026-06-05Davidar David DBuy25.00K$26.27656.75K
2026-06-05Davidar David DSell25.00K$80.762.02M
2026-06-05Davidar David DSell25.00K$26.27656.75K
2026-06-04RHOADS ANN DBuy25.00K$26.27656.75K
2026-06-04RHOADS ANN DSell25.00K$26.27656.75K
2026-02-25Huller KellySell20.00K$43.58871.60K
2026-02-25Huller KellyBuy20.00K$43.58871.60K
2026-02-25Huller KellySell20.00K$94.501.89M
2026-02-12Huller KellyBuy10.00K$45.64456.40K
2026-02-12Huller KellySell10.00K$87.67876.70K
2026-02-12Huller KellySell10.00K$45.64456.40K
2026-01-21Norwalk Leslie VBuy15.00K$94.151.41M
2026-01-21Pfeil Keith WBuy100.00K$94.159.41M
2026-01-21Kline KyleBuy30.00K$94.152.82M
2026-01-21Paul David CBuy100.00K$94.159.41M
2026-01-21Douglas Robert AndrewBuy15.00K$94.151.41M
2026-01-21Lemaitre DanBuy15.00K$94.151.41M
2026-01-21RHOADS ANN DBuy15.00K$94.151.41M
2026-01-21TOBIN JAMES RBuy15.00K$94.151.41M
2026-01-21ZARRILLI STEPHEN TBuy15.00K$94.151.41M
2026-01-21DeFord John ABuy15.00K$94.151.41M
2026-01-21Wolterman DanBuy15.00K$94.151.41M
2026-01-21Davidar David DBuy15.00K$94.151.41M
2026-01-21Huller KellyBuy40.00K$94.153.77M
2026-01-08Kline KyleSell3.59K$51.87186.42K
2026-01-08Kline KyleBuy3.59K$51.87186.42K
2026-01-08Kline KyleSell3.59K$101.10363.35K
2026-01-08Norwalk Leslie VSell2.00K$101.10202.20K
2025-12-12Norwalk Leslie VSell4.00K$88.85355.40K
2025-12-08Paul David CBuy34.38K$25.52877.25K
2025-12-08Paul David CSell34.38K$25.52877.25K
2025-12-01Kline KyleSell4.90K$63.68311.78K
2025-12-01Kline KyleBuy4.90K$63.68311.78K
2025-12-01Kline KyleBuy5.00K$64.44322.20K
2025-12-01Kline KyleSell5.00K$56.43282.15K
2025-12-01Kline KyleBuy5.00K$56.43282.15K
2025-12-01Kline KyleBuy3.65K$53.14193.75K
2025-12-01Kline KyleSell3.65K$53.14193.75K
2025-12-01Kline KyleSell5.00K$63.68318.40K
2025-12-01Kline KyleSell18.54K$90.001.67M
2025-12-01Kline KyleSell5.00K$64.44322.20K
2025-11-25Huller KellyBuy7.50K$25.96194.70K
2025-11-25Huller KellySell7.50K$25.96194.70K
2025-11-25Huller KellySell7.50K$90.00675.00K
2025-11-12Davidar David DBuy25.00K$25.52638.00K
2025-11-12Davidar David DSell25.00K$86.002.15M
2025-11-12Davidar David DSell25.00K$25.52638.00K
2025-11-11ZARRILLI STEPHEN TBuy25.00K$44.141.10M
2025-11-11ZARRILLI STEPHEN TSell25.00K$44.141.10M
2025-11-11ZARRILLI STEPHEN TSell25.00K$84.292.11M
2025-11-10RHOADS ANN DSell2.00K$85.00170.00K
2025-11-07RHOADS ANN DSell8.00K$81.00648.00K
2025-09-15RHOADS ANN DSell10.00K$58.46584.60K
2025-07-18Pfeil Keith WBuy40.00K$56.342.25M
2025-07-18Kline KyleBuy20.91K$56.341.18M
2025-07-18Kline KyleOther5.00K$80.17400.85K
2025-07-18Kline KyleOther5.00K$63.68318.40K
2025-07-18Kline KyleOther5.00K$53.14265.70K
2025-07-18Kline KyleOther15.00K$56.43846.45K
2025-07-18Kline KyleOther7.50K$51.87389.02K
2025-07-18Kline KyleOther9.09K$93.12846.55K
2025-07-18Kline KyleOther5.00K$64.44322.20K
2025-02-28RHOADS ANN DSell7.50K$78.68590.10K
2025-01-23Davidar David DBuy15.00K$92.421.39M
2025-01-23DeFord John ABuy15.00K$92.421.39M
2025-01-23Douglas Robert AndrewBuy15.00K$92.421.39M
2025-01-23Huller KellyBuy40.00K$92.423.70M
2025-01-23Lemaitre DanBuy15.00K$92.421.39M
2025-01-23Norwalk Leslie VBuy15.00K$92.421.39M
2025-01-23Paul David CBuy75.00K$92.426.93M
2025-01-23Pfeil Keith WBuy60.00K$92.425.55M
2025-01-23RHOADS ANN DBuy15.00K$92.421.39M
2025-01-23Scavilla Daniel TBuy140.00K$92.4212.94M
2025-01-23TOBIN JAMES RBuy15.00K$92.421.39M
2025-01-23Wolterman DanBuy15.00K$92.421.39M
2025-01-23ZARRILLI STEPHEN TBuy15.00K$92.421.39M
2025-01-10Pfeil Keith WBuy8.33K$53.27443.95K
2025-01-10Pfeil Keith WBuy5.83K$49.65289.61K
2025-01-10Pfeil Keith WSell12.50K$88.171.10M
2025-01-10Pfeil Keith WSell8.33K$53.27443.95K
2025-01-10Pfeil Keith WSell5.83K$49.65289.61K
2025-01-10Pfeil Keith WSell1.67K$89.17148.56K
2025-01-02Davidar David DSell6.10K——
2024-12-02Huller KellyBuy2.50K$24.2160.52K
2024-12-02Huller KellySell2.50K$87.00217.50K
2024-12-02Huller KellySell2.50K$24.2160.52K
2024-11-22Davidar David DSell6.77K$85.00575.14K
2024-11-22Davidar David DSell6.75K$85.00573.43K
2024-11-22Lemaitre DanBuy1.10K$65.0571.36K
2024-11-22Lemaitre DanSell1.10K$65.0571.36K
2024-11-22Lemaitre DanSell1.10K$85.0293.26K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 615, holders -7 vs prior quarter. Ownership 88.81%.

HolderSharesChangeChange %Value
BLACKROCK, INC.10.81M309.31K+2.95%853.84M
JUPITER TOPCO LLC8.20M8.20MNew647.93M
VANGUARD CAPITAL MANAGEMENT LLC5.11M74.80K+1.49%403.55M
VANGUARD PORTFOLIO MANAGEMENT LLC4.99M114.93K+2.36%394.61M
INVESCO LTD.4.31M-6.88K-0.16%340.52M
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC4.28M4.28MNew338.14M
STATE STREET CORP3.71M123.66K+3.44%293.54M
SCULPTOR CAPITAL LP3.00M-58.00K-1.90%237.03M
JPMORGAN CHASE & CO2.74M148.54K+5.72%230.76M
ALLIANCEBERNSTEIN L.P.2.38M629.51K+35.96%205.09M
BANK OF MONTREAL /CAN/2.43M118.31K+5.13%191.64M
DIMENSIONAL FUND ADVISORS LP2.37M599.41K+33.87%187.25M
GEODE CAPITAL MANAGEMENT, LLC2.15M40.89K+1.94%170.15M
GOLDMAN SACHS GROUP INC1.78M649.45K+57.36%140.76M
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP1.72M803.72K+88.04%135.63M
BOSTON TRUST WALDEN CORP1.57M318.45K+25.38%124.31M
BOSTON PARTNERS1.55M1.55MNew122.85M
ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC1.57M1.14M+267.18%119.38M
GW&K INVESTMENT MANAGEMENT, LLC1.45M-41.52K-2.78%114.82M
GENEVA CAPITAL MANAGEMENT LLC1.42M-343.90K-19.53%111.96M
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC1.28M-724.87K-36.07%101.52M
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P.1.25M1.25MNew98.47M
CHARLES SCHWAB INVESTMENT MANAGEMENT INC1.25M2.71K+0.22%98.47M
QUANTINNO CAPITAL MANAGEMENT LP1.22M672.00K+122.83%96.32M
NORGES BANK1.13M1.13MNew89.05M

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Globus Medical (GMED) Stock Price & Analysis

GMED$82.91+1.65 +2.03%

$11.13B

Market Cap

20.47

P/E

16.58

Forward P/E

70

Score

Price History